Large Rounds: Biotech and Fintech Lead the Week
The headline raise of the week came from Europe's life sciences sector, with an Oxford spin-out pulling in one of the largest biotech rounds seen this year.
- OMass Therapeutics: raised approximately $305M (EUR 275M) Series C, co-led by Bain Capital Life Sciences, Forbion, and Novo Holdings, with participation from Janus Henderson Investors, SV Health Investors, and Jefferson Life Sciences. The UK-based company develops small-molecule therapies against validated target ecosystems.
- ID Finance: landed EUR 545M in a deal that headlined the broader European funding week, signaling continued appetite for established fintech platforms operating across emerging markets.
Mid-Stage AI and Enterprise Platforms
Several growth-stage companies brought in meaningful rounds, with AI execution and enterprise learning among the standout themes.
- RapidCanvas: raised $29M in a Series B round. The company pairs an AI platform with field AI engineers who design, build, and stay accountable for custom AI applications delivered to enterprise customers.
- LearnUpon: the Dublin-based enterprise learning platform secured approximately $50M (EUR 44.5M) in growth debt financing from Claret Capital Partners, earmarked for scaling its agentic learning platform.
- Goodweek: the French-founded, Los Angeles-headquartered startup raised approximately $12M (EUR 10.7M) in a Seed round led by Adara Ventures. The company positions itself as an AI management platform for small and medium-sized businesses.
Biotech and Healthcare: Smaller Rounds with Big Implications
Beyond OMass, two other healthcare-focused companies closed rounds that reflect sustained investor interest in precision medicine and femtech.
- Microbiotica: the British clinical-stage biopharma company closed the first tranche of a EUR 42M Series C, led by British Business Bank, with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners. The company develops orally-dosed microbiome medicines targeting inflammatory bowel disease.
- Unravel Health: the London-based femtech startup raised approximately EUR 3M, led by Conduit EIS Impact Fund and Wrightwood, to develop its Micro Lab device, which reads multiple hormones from a saliva sample at home.
Early-Stage and Fintech
A handful of seed and pre-seed deals rounded out the week, spanning generative AI music and open banking infrastructure.
- GasLab: the generative AI music platform founded by DJ and producer Reinier Zonneveld raised $1M in pre-seed funding. The company, whose name stands for Generative AI Solutions Lab, aims to build AI-native tools for electronic music creators.
- Neonomics: the Norwegian open banking and open finance platform raised approximately EUR 3.6M from existing shareholders, having already cut its operating costs by nearly half ahead of the raise.
What This Week's Deals Signal
The relative quiet on mega-rounds this week, with only two financings in the multiple hundreds of millions, does not mean conviction is fading. Instead, the pattern across these deals points to a maturation in how capital is being deployed. Investors are writing substantial checks into biotech platforms with validated science, as the OMass and Microbiotica rounds illustrate, while also seeding a new generation of AI-native tools at the earliest stages, from SMB management software to generative music. The strong Q3 data out of Asia, where reported startup funding approached record highs on the back of AI investment, adds further context: the AI thesis is global, and Europe is increasingly competing for a share of that attention. Founders who can show accountable delivery, whether through clinical milestones or deployed AI engineers, appear to be finding the most receptive audiences.